This fundamental discrepancy may stem not only from differences between normal stem cell and transformed cancer cell metabolism but also from the cell-type-specific Mg2+ influx machinery, where the intestinal TRPM6/7 system in CRC is co-opted to support distinct, potentially more rigid oncogenic programs that are uniquely vulnerable to dysregulation. Here, TRPM6 is linked to colorectal carcinoma.